BioStack Microplate Stacker
- De-lidding and re-lidding microplates with fast plate exchange times
- Ultra-fast plate transfers with BioStack Neo
- Convenient re-stacking for complete automation of endpoint and kinetic processes
- 10, 30 and 50 plate removable, exchangeable stacks
- Super compact footprint saves bench space - and can fit in biosafety enclosure
applications
- Absorbance, fluorescence, luminescence assays
- ELISA
- Cell-based assays
BioStack4 has a unique 2-place carrier, design to make plate transfers super fast and enabling plate de-lidding and re-lidding.
These are just a few examples of the many important applications for BioStack. Visit our Applications page to see more.
BioTek Field Applications Scientists (FAS) and Product Specialists provide unparalleled scientific support, assisting with experimental planning and assay optimization on BioTek’s instrumentation and software. Learn how they can help move your science forward… faster!
Features
De-lidding and re-lidding capability
Fast plate transfers with BioStack Neo
Re-stacking for complete automation
Removable, exchangeable stacks
10, 30 and 50 plate stacks are available for use with BioStack to accommodate varying throughput requirements. Stacks are easily exchanged among multiple BioStacks in the lab, for maximum flexibility. The smaller stacks are compact to fit within a biosafety enclosure, and 50 plate stacks provide high throughput, walkaway automation.
Compact footprint
BioStack integrated to BioTek’s readers, imagers, washers or dispensers use minimal benchspace and are easily disconnected and moved as your lab space or layout changes. The integrated system can also fit conveniently within a biosafety enclosure to facilitate sensitive workflows.
Customer Spotlight
Live SARS-CoV-2 Research: Interlocking Pieces Working Together
9-June-20
When Dr. Robert Davey started researching Ebola virus drug development at the University of Texas Medical Branch (UTMB) at Galveston back in 2008, he had no idea just how keenly his work would prepare him to play a pivotal role in researching treatments for a very different global pandemic. In fact, a number of pieces fit together to support his current role in screening small molecule compounds that may be used in the fight against SARS-CoV-2, the novel coronavirus that causes COVID-19.